PTGER4P3

Across TCGA pan-cancer cohorts, PTGER4P3 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated PTGER4P3 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PTGER4P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PTGER4P3 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LGG show a favorable association.

LUAD, ACC, and DLBC are the cancer types where PTGER4P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.448	0.936	<.001	90	view →
ACC	OS	Tertile	III,IV	0.189	0.757	<.001	27	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
SKCM	OS	Tertile	III,IV	0.651	0.366	.033	6	view →
UCEC	DFS	Tertile	III,IV	0.620	0.808	.046	6	view →
LGG	OS	Tertile	All	0.955	0.864	.015	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

PTGER4P3–LUAD (DFS)

Open the LUAD breakdown →